Pancreatic Cancer Research

ResearcherTufts UniversityActive in the last 2 years

Eduardo A. Vega

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4643-0634; OpenAlex author ID A5101849259. Sources: OpenAlex.

Their work

Papers
6 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 6

  1. The impact of the COVID-19 pandemic on patients with pancreatic cancer. First author DOI 10.1016/j.gassur.2024.03.008↗
  2. R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. First author DOI 10.1016/j.suronc.2023.101961↗
  3. Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress? First author DOI 10.1007/s11605-022-05336-7↗
  4. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage. Co-author DOI 10.1016/j.suronc.2021.101694↗
  5. ASO AUTHOR REFLECTIONS: Laparoscopic Distal Pancreatectomy for Pancreatic Cancer: Good, Bad, or Even Ugly? First author DOI 10.1245/s10434-021-10332-3↗
  6. Preoperative Chemotherapy for Pancreatic Cancer Improves Survival and R0 Rate Even in Early Stage I. Co-author DOI 10.1007/s11605-020-04601-x↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudius H. Conrad · 6 shared papers, 2020–2024 · strength 1.02
  2. Omid Salehi · 5 shared papers, 2020–2024 · strength 0.84
  3. Onur Cagri Kutlu · 5 shared papers, 2020–2023 · strength 0.79
  4. Oscar Salirrosas · 2 shared papers, 2023–2024 · strength 0.41
  5. Sebastián Mellado · 2 shared papers, 2022–2023 · strength 0.33
  6. Ariana M. Chirban · 1 shared paper, 2023 · strength 0.18
  7. David J. Lee · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.